Peptide-Based Diagnostic Testing and Clinical Biomarkers
Peptides serve as crucial biomarkers in clinical diagnostics, providing insights into pancreatic function, cardiac health, and autoimmune conditions. This hub covers the science behind peptide-based diagnostic tests, how to interpret lab results, and what these biomarkers reveal about underlying health conditions.
Key Diagnostic Peptides
- C-Peptide: marker for endogenous insulin production and beta cell function
- BNP (B-type Natriuretic Peptide): cardiac stress and heart failure indicator
- Pro-BNP (NT-proBNP): extended cardiac biomarker with longer half-life
- CCP Antibody (Anti-Cyclic Citrullinated Peptide): rheumatoid arthritis diagnosis
Why Peptide Biomarkers Matter
Peptide biomarkers provide clinicians with precise, quantifiable measures of organ function and disease activity. C-peptide testing, for example, distinguishes between Type 1 and Type 2 diabetes by measuring residual beta cell function — information that directly impacts treatment decisions. BNP and NT-proBNP levels correlate with the severity of heart failure and guide both diagnosis and therapeutic monitoring.
Anti-CCP antibodies are among the most specific markers for rheumatoid arthritis, often detectable years before clinical symptoms appear. Our articles explain the science behind each test, provide reference ranges, and help readers understand what their lab results mean in clinical context.
